12:00 AM
 | 
Apr 03, 2000
 |  BC Week In Review  |  Company News  |  Other News

Amgen, Transkaryotic, Aventis Pharmaceuticals Inc. renal, hematology news

A judge in the U.S. District Court for the District of Massachusetts adopted AMGN's definitions of four patent claim terms, with minor modifications, at a Markman hearing last week regarding...

Read the full 128 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >